TimesSquare Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
TimesSquare Capital Management's ASND Position: Q4 2024 in Review
TimesSquare Capital Management sold out of Ascendis Pharma (ASND) in Q4 2024, closing a stake of 500,920 shares — an estimated $74.8M sold.
TimesSquare Capital Management first reported a position in ASND in Q2 2020 and held it in 18 quarters. The position peaked at $100M in Q4 2023. 214 funds tracked by Wall St. Rank hold ASND as of Q4 2024.
- TimesSquare Capital Management reported no remaining Ascendis Pharma position as of Q4 2024 after selling out during the quarter.
- TimesSquare Capital Management sold 500,920 Ascendis Pharma shares in Q4 2024, an estimated $74.8M.
- TimesSquare Capital Management first reported a position in Ascendis Pharma in Q2 2020 and held it in 18 quarters.
- TimesSquare Capital Management's Ascendis Pharma position peaked at $100M in Q4 2023.
- 214 funds tracked by Wall St. Rank held Ascendis Pharma as of Q4 2024.
Based on TimesSquare Capital Management's 13F filing for Q4 2024, filed 3 Feb 2025.